7月3日,“眼科创新药新锐”Cloudbreak Pharma Inc.拨康视云(02592.HK)在港交所正式上市。配发结果显示,拨康视云全球发售6058.2万股股份,占发行完成后总股份的7.22%,其中香港公开发售1211.55万股,国际发售4846.65万股。最终发售价为每股10.10港元,获得款项总额为6.12亿港元,所得款项净额5.22亿港元。截至今日港股收盘,总市值为52.01亿港元。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.